The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.

Read this story here.

Learn about your ad choices: dovetail.prx.org/ad-choices